Transaction DateRecipientSharesTypePriceValue
12th January 2021Morana Jovan Embiricos1,136,525Conversion of derivative$0.00
12th January 2021Morana Jovan Embiricos2,912,345Conversion of derivative$0.00
12th January 2021Morana Jovan Embiricos182,135Conversion of derivative$0.00
12th January 2021Morana Jovan Embiricos639,295Conversion of derivative$0.00
12th January 2021Morana Jovan Embiricos71,599Conversion of derivative$0.00
12th January 2021Morana Jovan Embiricos455,338Conversion of derivative$0.00
12th January 2021Morana Jovan Embiricos95,238Open or private purchase$21.00$1,999,998.00
12th January 2021Morana Jovan Embiricos214,798Conversion of derivative$0.00
12th January 2021Morana Jovan Embiricos71,599Conversion of derivative$0.00
12th January 2021Morana Jovan Embiricos143,198Conversion of derivative$0.00
Tcr2 Therapeutics
Tcr2 Therapeutics logo

TCR2 Therapeutics, Inc. is an immunotherapy company. It develops biological drugs and engineering T-cells for cancer therapy. The company was founded in May 2015 and is headquartered in Cambridge, MA.


Ticker: TCRR
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1750019
Employees: 83
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $50 M (0%)
Assets, Current: $134 M (-18%)
Property, Plant and Equipment, Net: $6 M (0%)
Assets: $140 M (-16%)
Accounts Payable, Current: $3 M (20%)
Accrued Liabilities, Current: $3 M (0%)
Liabilities, Current: $6 M (-15%)
Other Liabilities, Noncurrent: $609 Th (11%)
Liabilities: $7 M (-13%)
Common Stock, Value, Issued: $2 Th (0%)
Common Stock, Shares, Issued: $24 M (0%)
Additional Paid in Capital, Common Stock: $347 M (1%)
Retained Earnings (Accumulated Deficit): $214 M (17%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $402 Th (183%)
Stockholders' Equity (Parent): $133 M (0%)
Liabilities and Equity: $140 M (-16%)
Research and Development: $13 M (-48%)
General and Administrative Expenses: $4 M (-52%)
Operating Income/Loss: $17 M (-49%)
Other Income, net: $499 Th (-59%)
Provision for income taxes: $28 Th (-49%)